ArticleSAGE open medicine2026
Article in SAGE open medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic kidney disease is on the rise globally and poses a significant public health concern. Patients with chronic kidney disease are receiving sustainable treatment through hemodialysis. However, hemodialysis is intensive, costly, and requires regular treatment. This study aims to explore the lived experiences of patients undergoing hemodialysis treatment. Methods: This study employed a phenomenological qualitative approach conducted between May and August 2023. Semi-structured, in-depth interviews were used with 16 participants selected purposively. Data were collected using an audio tape recorder and a notebook, and data collection ceased upon achieving thematic saturation. The data were analyzed using thematic analysis. Results: Seven themes were identified: (1) Threads of survival, (2) the price of survival, (3) the thirst of survival, (4) psychological and emotional distress, (5) physical effects, (6) social concerns, and (7) coping with treatment and the disease. Conclusion: Understanding the lived experiences of patients with end-stage renal disease and their coping mechanisms is crucial for healthcare providers in planning and delivering quality care, that is, centered on patient experiences. By focusing on what patients go through daily and how they manage their condition, healthcare providers can develop care plans that are not only effective but also empathetic and supportive. Expanding dialysis services, reducing costs, and emphasizing early chronic kidney disease detection and prevention are critical to reduce the burden.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.